Infection with Fasciola hepatica

Creative Commons License

Aksoy D., Kerimoglu U., Oto A., Erguven S., Arslan S., ÜNAL S., ...Daha Fazla

CLINICAL MICROBIOLOGY AND INFECTION, cilt.11, sa.11, ss.859-861, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 11 Sayı: 11
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1111/j.1469-0691.2005.01254.x
  • Dergi Adı: CLINICAL MICROBIOLOGY AND INFECTION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.859-861
  • Anahtar Kelimeler: diagnosis, Fasciola hepatica, fascioliasis, liver fluke, treatment, DIAGNOSIS
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Fascioliasis, caused by the liver fluke Fasciola hepatica, is an infection that occurs worldwide, although humans are accidental hosts. F. hepatica infection comprises two stages, hepatic and biliary, with different signs and symptoms. Stool examination and ELISA can be used for the initial diagnosis. Radiographic techniques, such as computerised tomography and ultrasonography, as well as magnetic resonance imaging, are used widely for confirmation and follow-up of the disease. Invasive techniques, such as percutaneous cholangiography, endoscopic retrograde cholangiography and liver biopsy, may aid in the diagnosis but are not essential. Triclabendazole is recommended as the first-line agent for the treatment of F. hepatica infection, with bithionol as an alternative.